Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teladoc Health, Inc.TDOC · Entity 1547 | President of BetterHelp | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teladoc Health, Inc.
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-09-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2026-09-01 · Exercise / conversion · Acquired 5,492 · Balance 5,492 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 2 · 2026-09-01 · Exercise / conversion · Acquired 1,042 · Balance 6,534 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 3 · 2026-09-01 · Exercise / conversion · Acquired 8,717 · Balance 15,251 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Row 4 · 2026-09-02 · Sale · Disposed 5,439 · Balance 9,812 F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Row 5 · 2026-09-03 · Sale · Disposed 9,812 · Balance 0 F3: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 5,492 |
Reported balance
After 2026-09-01 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-01 · Exercise / conversion · Disposed 5,492 · Balance 5,492 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 2,084 |
Reported balance
After 2026-09-01 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-01 · Exercise / conversion · Disposed 1,042 · Balance 2,084 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F5: On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 52,302 |
Reported balance
After 2026-09-01 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-09-01 · Exercise / conversion · Disposed 8,717 · Balance 52,302 F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F6: On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
F2: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
F3: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on November 3, 2025.
F4: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
F5: On March 19, 2024, the reporting person was granted 12,500 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
F6: On March 1, 2025, the reporting person was granted 104,602 restricted stock units, vesting one-third on March 1, 2026, with the remainder vesting in eight substantially equal quarterly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2025 Filed Mar 4, 2025 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 5,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001477449-25-000021 · wk-form4_1741122428.xml · derivative · entry 3 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,439 Underlying: Common Stock · 5,491 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F3 · derivative.exercise_date: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F3 · derivative.expiration_date: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 21:07 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,491 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001477449-25-000021 · wk-form4_1741122428.xml · nonDerivative · entry 1 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,491 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
| December 03, 2024 Filed Dec 3, 2024 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 14,091 | $11.07 | $156,001.46 |
DisclosureSEC source: 0001628280-24-049794 · wk-form4_1733264807.xml · nonDerivative · entry 3 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F3 · price: Represents the weighted average price of transactions ranging from $11.07 to $11.085, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4. Read SEC document |
| December 02, 2024 Filed Dec 3, 2024 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 7,873 | $11.93 | $93,901.27 |
DisclosureSEC source: 0001628280-24-049794 · wk-form4_1733264807.xml · nonDerivative · entry 2 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,091 F2 · shares: Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionRestricted Stock Units · Derivative | 21,964 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-049794 · wk-form4_1733264807.xml · derivative · entry 4 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,930 Underlying: Common Stock · 21,964 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. F4 · derivative.exercise_date: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. F4 · derivative.expiration_date: On December 1, 2023, the reporting person was granted 65,894 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. Read SEC document |
| November 29, 2024 Filed Dec 3, 2024 22:26 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 21,964 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-24-049794 · wk-form4_1733264807.xml · nonDerivative · entry 1 Rodrigues Fernando M. · CIK 0002037547 · President of BetterHelp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert to shares of TDOC common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.